Lumexa Imaging (LMRI) vs Tandem Diabetes Care (TNDM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tandem Diabetes Care is the larger company by market cap ($1.09 billion vs $1.01 billion), about 1.1 times the size. On valuation, Lumexa Imaging trades at a lower forward P/E (11.9x vs 98.9x for Tandem Diabetes Care).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMRI | TNDM |
|---|---|---|
| Share price | $10.56 | $15.72 |
| Market cap | $1.01B | $1.09B |
| 1-day change | +2.23% | +0.29% |
| YTD return | -44.16% | -28.69% |
| 1-year return | — | +2.18% |
| 5-year return | — | -87.50% |
| Forward P/E | 11.86 | 98.89 |
| EPS (TTM) | $-0.37 | $-0.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.45 | $29.65 |
| 52-week low | $6.45 | $12.26 |
| Distance from 52-week high | -45.71% | -46.98% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +67.33% | +77.23% |
| Average volume | 430.76K | 2.01M |
| Shares outstanding | 96.07M | 69.58M |
| Employees | 5,000 | 2,500 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
About Tandem Diabetes Care
TNDM stock →Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
Health Care · Medical/Dental Instruments · 2,500 employees
LMRI vs TNDM FAQ
Which is bigger, Lumexa Imaging or Tandem Diabetes Care?
Tandem Diabetes Care (TNDM) is larger, with a market capitalization of $1.09B compared with $1.01B for Lumexa Imaging (LMRI).
Are Lumexa Imaging and Tandem Diabetes Care in the same industry?
Both are in the Health Care sector, but in different industries: Medical Specialities for Lumexa Imaging and Medical/Dental Instruments for Tandem Diabetes Care.